OAV · Class II — Moderate Risk (510(k) clearance required) · Clinical Toxicology · 21 CFR 862.3840
Classification
FDA Product Code
OAV
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 862.3840
Review panel
TX
Medical specialty
Clinical Toxicology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
Y
Definition
An in vitro diagnostic reagent system intended for use in the quantitative determination of total mycophenolic acid in human serum or plasma as an aid in the management of mycophenolic acid therapy in renal and cardiac transplant patients.